Pfizer had tried, raising the offer from 100 to 106 billion dollars, but AstraZeneca resisted and balked: "The offer continues to underestimate the value of the company", reads a statement in which the British pharmaceutical group also held to let it be known that the new refusal was decided "without hesitation".
The pharma "war" continues, which has been inflaming the markets so much since last week. The object of desire is always the group AstaZeneca, to obtain which the American pharmaceutical group Pfizer had tried to raise the offer for the acquisition a 106 billion dollars, proposing a consideration of 50 pounds for each share of the British pharmaceutical company.
